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Neuroserpin (NS) is a serpin inhibitor of tissue plasminogen activator (tPA) in the brain. The 
polymerisation of NS pathologic mutants is responsible for a genetic dementia known as familial 
encephalopathy with neuroserpin inclusion bodies (FENIB). So far, a pharmacological treatment 
of FENIB, i.e. an inhibitor of NS polymerisation, remains an unmet challenge. Here, we present a 
biophysical characterisation of the effects caused by embelin (EMB a small natural compound) on NS 
conformers and NS polymerisation. EMB destabilises all known NS conformers, specifically binding to 
NS molecules with a 1:1 NS:EMB molar ratio without unfolding the NS fold. In particular, NS polymers 
disaggregate in the presence of EMB, and their formation is prevented. The NS/EMB complex does not 
inhibit tPA proteolytic activity. Both effects are pharmacologically relevant: firstly by inhibiting the NS 
polymerisation associated to FENIB, and secondly by potentially antagonizing metastatic processes 
facilitated by NS activity in the brain.
Neuroserpin (SERPINI1) (NS) is a member of the serpin superfamily, whose members are mainly serine-protease 
inhibitors1. Typically the native serpin fold displays a long loop named reactive center loop (RCL), which is used 
as a bait that is recognised and cleaved by the target protease. Such cleavage triggers the insertion of the RCL 
N-terminal portion into NS A β -sheet, between strands 3A and 5A (secondary structure elements are named 
according the accepted serpin nomenclature)2. Following this conformational change, the active site of the tar-
geted protease is geometrically distorted and the acyl-enzyme adduct is not hydrolysed3. The resulting covalent 
complex is then cleared2.
The ability of serpins to carry out the conformational change described above, reflects the accepted notion 
whereby the serpin native conformation is meta-stable relative to the cleaved conformer, which is reflected by 
a sizeable free energy gain4. The meta-stability of the native conformation, which is at the root of the inhibition 
mechanism, is also the cause of a number of pathologies collectively known as serpinopathies5. In these diseases 
specific mutations destabilise the serpin fold and the mutated molecules tend to form polymers (Pol) and latent 
conformation (Lat)6–8. The latter is an uncleaved monomeric species whose uncleaved RCL is inserted into the 
A β -sheet, as described for the cleaved serpins9, in some serpins Lat plays a physiological role10. Conversely, the 
organisation of the polymeric species is not fully understood yet, and different structural models have been pro-
posed. In all Pol models, however, the RCL is partly or completely responsible for polymerisation and is thought 
to be inserted into the A β -sheet of a neighbouring molecules6,11,12. Both Pol and Lat species are much more stable 
than the native conformation, and both are inactive as protease inhibitors13. The intracellular accumulation of 
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mutant serpin Pol results in the formation of inclusion bodies leading to loss- and gain-of-function diseases2. To 
date no pharmacological treatment against serpin Pol formation and accumulation is available.
NS is an axonally secreted serpin, known to play a role in synaptic plasticity, memory and permeability of the 
neurovascular compartment14,15: it is the neuronal inhibitor of tissue plasminogen activator (tPA) in the nervous 
system1. Several mutated NS variants have been found to be responsible for an early onset dementia known as 
Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB), related to NS polymer accumulation16. 
Evidences from in vitro and in vivo studies indicate that mutant NS accumulates as polymers within the endoplas-
mic reticulum of the expressing cells17–20. Interestingly, a new pathologic role for NS has been recently reported: in 
fact, the proteolysis inhibitory activity played by wild type (wt) NS was found to have a protective role for cancer 
cells thus promoting brain metastasis21.
Analogously to other serpins, native NS (Nat) displays an exposed and flexible RCL, which is inserted into 
β -sheet A following protease cleavage22. Lat and Pol species can be prepared in vitro by heating wt NS: such con-
formations display markedly higher stability than Nat17,23. Recent studies have shown that, once polymerised, NS 
displays an overall native-like conformation with just a moderate gain in secondary structure content, in keeping 
with the hypothesis that the RCL is structured in the polymers23,24. Such polymers are soluble and linear, and the 
kinetics of polymerisation depend both on temperature and wt NS concentration25. Recently Noto and co-workers 
reported that the NS intrinsic fluorescence can be diagnostic of the different protein conformations: in particular, 
the Nat to Pol conversion could be monitored by Trp/Tyr fluorescence13.
Several reports over the last few years focused on the effects of low molecular weight inhibitors of serpin 
polymerisation. Lomas and coworkers reported that a lateral hydrophobic cavity formed by strands S1A, S2A 
and hD is a source of instability in α 1-antitrypsin26. The introduction of bulky hydrophobic residues filling this 
cavity resulted in stabilisation and decreased polymerisation trends. Some molecules binding that cavity selected 
by an in silico docking screen displayed an anti-polymerisation effect27. Recently, Andreasen and coworkers have 
shown that embelin (EMB), a compound originally discovered in the Japanese Ardisia herb, acts as an antagonist 
of PAI-1, a distinct serpin inhibitor of plasminogen activation and of tPA28. Upon incubation with EMB, PAI-1 
loses its inhibitory activity against urokinase-type plasminogen activator (uPA) and the suicide uPA-PAI-1 covalent 
complex is not evidenced by SDS-PAGE analysis. The crystal structure of the complex indicates that EMB binds 
to PAI-1 in a pocket formed by strands 1 and 2 of the A β -sheet and by helices B and D, structural similarity and 
sequence identity between NS and PAI-1 are shown in figure S1.
To date no inhibitors of NS polymerisation are known thus FENIB remains a severe incurable disease. The 
present study thus stems from the evident need to identify a small molecule able to inhibit the polymerisation 
of NS pathologic mutants. Given the high level of structural homology between PAI-1 and NS, we set up to 
investigate the potential of EMB as an inhibitor of NS polymerisation. The data here reported indicate that the 
effects of EMB on NS extend well beyond what was reported for PAI-1. EMB binds to all four NS conformations 
(native, cleaved, latent and polymer) and in particular it affects both Pol and Lat, the NS conformers accumulated 
in FENIB patients. In our hands, EMB prevents the polymerisation of Nat, it dissolves preformed NS polymers 
and it destabilises the Lat form. The NS/EMB 1:1 stoichiometric complex tends to form small oligomers, which 
do not inhibit tPA activity but, conversely, are hydrolysed by tPA, an event, that may help the clearance of the NS 
pathologic deposits. Our results indicate that EMB exerts remarkable effects on the NS fold significantly modifying 
its conformational stability. Compounds displaying such effects have long been sought as starting hits to control 
the NS polymerisation, hence addressing therapeutic approaches for FENIB.
Results
Embelin affects the stability of all NS conformers. Due to the high level of structural conservation 
between PAI-1 and NS, we tested whether EMB exerts any structural or functional effect on wt NS. First, the 
typical Nat transitions to Pol and Lat conformers were explored in the presence of EMB. According to previously 
reported protocols, Pol and Lat conformers were concomitantly produced by heating wt NS at 45 °C and separated 
by SEC723. The effects of EMB on Nat were monitored by size exclusion chromatography (SEC) analysis after over-
night incubations at 4, 20, 37 and 45 °C in presence of 1.5 mM EMB (Fig. 1A). As standards the SEC profiles of Nat 
and Pol are shown: Nat alone is eluted at a volume of 14.5 ml (black line), while Pol is eluted in the column dead 
volume (VR = 7.1 ml, dashed line), suggesting a mass over a half million Dalton in keeping with previous data23. 
After the incubation at 4 °C (blue line), NS is eluted with a major peak at 13.7 ml and a shoulder at 12.5 ml, while 
upon incubation at 20 °C (green line) the species at 12.5 ml became more abundant. At higher temperatures (37 and 
45 °C, yellow and red lines, respectively) the height of the 13.7 ml peak decreased and a broad peak centred at 9.5 ml 
became the main peak. It is noteworthy that in absence of EMB, Nat is stable after incubations at low temperatures 
(4 and 20 °C) while yields polymeric species at higher temperatures (37–55 °C) (Fig. 1A and Fig. S2A,B). Increasing 
the temperature to 55 °C (Fig. S2A,B) led to SEC profiles similar to the one shown for NS incubated at 45 °C. This 
observation indicates that under the present conditions the oligomerisation process reaches the end state during 
overnight incubation at 45 °C. Interestingly, SDS-PAGE analysis of the SEC fractions indicates that the oligomers 
consist only of uncleaved NS (Fig. S2B). Cleaved NS (Cle), if present as in the experiment shown in figure S2B, is 
eluted only in the monomeric fractions, while the Lat conformer typically formed during incubation of Nat at high 
temperatures23 is virtually absent (Fig. S2B,C). Analysis of the incubation and elution data reported suggests that 
the oligomerisation may occur according to the following steps: first the species eluted at 13.7 ml peak is formed, 
followed by one eluted at 12.5 ml; finally, most NS accumulates in the broad peak centred around 9.5 ml, while 
the 13.7 ml peak disappears (Fig. S2C,D). Moreover, the oligomerisation rate can be accelerated by increasing Nat 
concentration (Fig. S2E). The data here shown indicate that the presence of EMB triggers the formation of small 
NS oligomers while preventing the formation of NS polymers.
In order to define the molecular mass of the species formed during the incubation with EMB, a multi-angle light 
scattering (MALS) analysis was performed on Nat, and on the species eluted at 13.7 and 12.5 ml (Fig. S3). MALS 
www.nature.com/scientificreports/
3Scientific RepoRts | 6:18769 | DOI: 10.1038/srep18769
estimated a molecular mass of 43.1 ± 0.8 kDa for Nat and of 43.3 ± 0.9 kDa for the peak centred at 13.7 ml, both 
compatible with a monomeric species. The peak with a retention volume of 12.5 ml corresponds to a molecular 
mass of 81.5 ± 1.6 kDa, thus suggesting a dimeric species. The mass of the broad peak centred at 9.5 ml could not 
be estimated by MALS due to the coelution of species of higher molecular weight that, although in low amount, 
contribute substantially to the LS signal.
SEC analysis was also performed to evaluate the effects of EMB on the other three NS conformers. Lat, Pol and 
Cle were incubated at 45 °C overnight in an EMB solution. The SEC profiles shown in Fig. 1B indicate that Cle 
remains monomeric after the incubation (blue line), while Lat appears destabilised, since the SEC profile displays 
aggregates similar to those of Nat incubated with EMB (red line). Most surprisingly after overnight incubation 
at 45 °C the high molecular weight Pol is largely dissolved (Fig. 1B dashed line) and species comparable to those 
observed after the overnight incubation of Nat at 45 °C are formed. Varying the temperature of the overnight 
incubations affects the depolymerisation kinetics but not the final oligomeric species obtained (Fig. S2F).
Embelin prevents NS polymerisation. The effect of EMB on the NS polymerisation kinetics was moni-
tored by native PAGE and by intrinsic fluorescence (Fig. 2). According to previous data17,23, native PAGE moni-
toring the incubation of Nat at 45 °C shows polymeric species of increasing molecular weight over time, together 
with a small amount of monomeric Lat (Fig. 2A left panel, Fig. S2C). Instead, in the presence of EMB only small 
oligomers are formed starting from 15 min of incubation: their size distribution remains stable over time, with no 
signs of Lat formation (Fig. 2A, right panel, Fig. S2C).
We have previously reported that Trp photoluminescence (PL) emission can be used to discriminate between 
Nat and Pol conformers13, in particular a red shift of the first moment of the PL emission spectrum can be assigned 
to the progress of polymer formation25. Figure 2B shows NS polymerisation kinetics in the presence and absence 
of EMB. At all the tested temperatures a clear red shift in PL first moment indicates that NS polymerises during 
the experiment (Fig. 2B). When NS was pre-incubated with EMB (2 hours at 4 °C) such red shift was virtually 
absent, indicating that the Pol conformer is not formed. A measurable but much reduced inhibition of NS polym-
erization can be appreciated when aggregation kinetics are performed at lower EMB concentration (molar ratio 
1:5 NS:EMB) (Fig. S4).
All NS conformers interact with EMB. In order to assess whether the effects described above are due 
to a direct interaction between EMB and the NS conformers or are the result of unspecific effects due to the 
presence of EMB, the coelution of EMB together with NS oligomers was analysed by SEC (Fig. 3). The elution 
of NS (with or without EMB, black continuous and dashed lines, respectively) was monitored at 280 nm, while 
that of EMB was followed at 340 nm (red lines). Figure 3 shows the results obtained after an overnight incubation 
at 45 °C for each of the four NS conformers. The profiles at 280 nm and 340 nm were perfectly superimposable, 
indicating that NS and EMB co-eluted hence that EMB directly bound all NS conformers. It is noteworthy that 
Lat is highly destabilised upon incubation with EMB, and tends to form oligomers similarly to what observed 
for the Nat and Pol forms. Cle is the only NS conformer, which does not form oligomers upon incubation with 
EMB; however a minor shift in the elution volume of Cle before and after incubation with EMB is evident (Cle 
panel, VR cle = 14.9 ml; VR cle+emb = 14.5 ml), analogously to what is observed for the Nat conformer (Fig. 1A). In 
summary, Fig. 3 shows that EMB is bound to each of the species that are observed after incubations: monomeric 
non-cleaved NS (VR 13.7ml) (Fig. 3: Nat, Lat, Pol panels), monomeric Cle (Fig. 3: Cle panel) and all the oligo-
meric species of any size (Fig. 3: Nat, Lat and Pol panels).
Figure 1. SEC analysis of the effects of EMB on NS conformers. (A) SEC profile of Nat (4 mg/ml) incubated in a 
saturated EMB solution overnight at different temperatures (4, 20, 37, 45, 55 °C); Nat alone and Pol are reported 
as controls. (B) SEC profile of Pol, Lat and Cle conformers (1.7 mg/ml) incubated with EMB overnight at 45 °C.
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Figure 3E shows the comparison of the absorption spectra of Nat and Nat incubated with EMB. The green and 
red spectra refer to absorption of solutions of 60 μ M EMB and of 8.2 μ M Nat, respectively. A Nat sample was incu-
bated for 2 hours at 4 °C with EMB, then the excess free EMB was removed by buffer exchange; the corresponding 
spectrum is shown in black (Fig. 3E). Such spectrum clearly indicates that EMB directly interacts with NS. The 
difference spectrum of the NS/EMB complex, once the Nat and EMB individual contributions are subtracted is 
shown in blue. Broadening of the overall EMB absorption band, when complexed with NS, is highlighted by the 
appearance of a new absorption peak with a maximum at 340 nm in the difference spectrum (blue curve); such 
observation points to a specific interaction between NS and EMB. Moreover, the height of the 340 nm peak in 
the difference spectra proportionally increases with NS concentration in the sample (data not shown). Figure 3E 
(inset) shows that such peaks are readily superimposable if normalized for NS concentrations, thus suggesting a 
specific stoichiometric ratio between NS and the interacting EMB molecule(s).
The NS/EMB complex has a defined stoichiometry. Mass spectrometry (MS) has been used in order 
to directly visualize the NS complexes with EMB and to determine its binding stoichiometry. Nat or Nat incubated 
overnight at 20 °C with EMB was subjected to SEC, and the monomeric and oligomeric species were analysed by 
electrospray-ionization mass spectrometry (ESI-MS) under non-denaturing conditions (native MS). Native MS 
can properly identify supramolecular complexes within heterogeneous mixtures deriving from protein-protein 
and protein-ligand interactions, offering combined information about the fold state and the binding properties of 
each detected species29,30. Figure 4A shows the spectrum of Nat (peak eluted at VR 14.5 ml in SEC), corresponding 
to a highly pure species of 46285.5 Da, almost identical to the NS calculated mass including a N-terminal initial 
formylmethionine (46285 Da). The narrow charge-state distribution (CSD) is compatible with a folded protein 
in a compact conformation31. An enlargement of the main peak (15+ ) does not reveal any signal at the mass 
expected for the NS/EMB complex (Fig. 4B).
After incubation with EMB, the monomeric fraction shows a similar spectrum (Fig. 4C), but peak enlarge-
ment reveals the appearance of a new signal with an average mass shift of 292 ± 1.7 Da, therefore identifiable as 
the 1:1 NS/EMB complex (Fig. 4D). No peaks corresponding to higher stoichiometric ratios are detectable. It is 
noteworthy that the acquisition of high-quality data for all the samples here reported, required the application of 
unusually high declustering potential (around 300 V). This peculiarity is likely due to intrinsic NS properties and 
not to the presence of EMB or protein aggregates. High values of declustering potential are expected to promote 
in-source dissociation of the protein-ligand complex during electrospray. Therefore, the relative amount of the 
complex is underestimated under the experimental conditions here employed. Nevertheless, these results provide 
a direct evidence of EMB binding to monomeric NS, and indication of complex formation with 1:1 stoichiometry. 
Figure 2. Time-course analysis of NS polymerisation. (A) Non-denaturing PAGE analysis of Nat 
polymerisation upon incubation for 0, 15, 30, 45, 60, 120 and 180 min at 45 °C in the absence (left panel) or in 
the presence (right panel) of saturating concentration of EMB. (B) Kinetics of NS polymerization monitored 
by PL emission (excitation wavelength 275 nm). First moment of the emission spectra of NS (5 μ M, pH 8) 
incubated as indicated. Nat samples were either incubated directly at high temperature (circles) or previously 
pre-incubated with EMB at saturating concentration for 2 h followed by removal of unbound EMB by buffer 
exchange (squares).
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Figure 3. EMB directly interacts with NS conformers. (A–D) SEC profiles for identified NS conformers after 
overnight incubation (1.7 mg/ml) in the presence or absence of EMB at 45 °C; A: Nat, B: Pol, C: Lat, and D: Cle. 
The continuous black line corresponds to NS in the absence of EMB, monitored at 280 nm; the dashed black 
line and the red line are the SEC profiles after NS incubation with EMB, monitored at 280 nm and at 340 nm 
respectively. (E) Absorption spectra of a 8.2 μM NS solution (green line) and of a 60 μM EMB solution (red 
line); Nat incubated for two hours in saturated EMB solution and then washed to remove free EMB (black line); 
difference spectrum between the black spectrum and the previous two spectra (Nat and EMB solutions) (blue 
line). Inset: difference spectra calculated as above at different NS concentrations. Each spectrum is normalised 
for NS concentration.
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It should also be noted that the complex is detected following removal of free EMB through SEC, further suggest-
ing that the observed complexes are stable and specific. Finally, the MS results indicate that ligand binding does 
not significantly affect the NS fold, since the average charge states of the free and complexed protein are closely 
comparable (14.8 and 15.1, respectively).
The SEC peak corresponding to higher molecular weights (VR 12,5 ml), displays a drastically different spec-
trum relative to those described above, with peak envelopes corresponding to monomeric, dimeric, trimeric and 
tetrameric NS (Fig. 4E–H). The dimers, trimers and tetramers yield deconvoluted mass values of 92571.6 ± 3.2 
Da, 138856.3 ± 2.8 Da and 185151.2 ± 14.5 Da respectively. These signals are completely absent in the spectra of 
the SEC peak corresponding to monomeric NS, although the final protein concentration in the eluted fractions 
is comparable (around 0.5 mg/ml). Thus, it can be ruled out that the observed complexes are unspecific products 
induced by the electrospray process. This result confirms that NS incubation in the presence of EMB mainly yields 
low-order protein oligomers. These oligomeric species are also complexed with EMB, as shown by the adducts in 
figure 4F,G. NS oligomers display a maximum of number of bound EMB molecules equal to the number of protein 
subunits, suggesting that 1:1 stoichiometry characterizes oligomeric as well as monomeric NS/EMB complexes. 
The average mass shift due to adduct formation with the ligand in the peaks of the oligomers is 294 (± 2) Da per 
NS chain (Embelin molecular mass is 294.39 Da). The CSD also indicates that the NS molecules associated into 
these oligomers assemble in compact species, as the average charge states approximate the values expected for 
folded globular proteins of the same mass (Fig. 4I)31. In order to rule out unspecific interactions between NS and 
EMB, Nat incubated with EMB was analysed by ESI-MS without a gel filtration step, therefore maintaining the 
large molar excess of EMB in the sample. In this case the NS/EMB complex displaying 1:1 molar ratio was the 
only one found as the in gel filtered samples described above (Fig. S5). Furthermore, ESI-MS spectra of control 
proteins (transferrin and cytochrome C) incubated with EMB using the same incubation procedure as in Fig. 4, 
do not reveal any protein/EMB complex (Fig. S6).
Embelin interaction triggers conformational changes distinct from polymer formation. In 
order to investigate whether the interaction of EMB with NS triggers any conformational rearrangement, circular 
dichroism (CD) spectra of NS conformers in the presence or absence of EMB were recorded (Fig. 5). The far-UV 
CD spectra of Nat and Pol before and after incubation with EMB are shown in figure 5A. Analysis of these spectra 
indicates that NS does not unfold upon interaction with EMB but just minor differences at 195 and 220 nm are 
observable. It is noteworthy that after incubation with EMB, Nat and Pol spectra display a similar shape, suggest-
ing that the interaction with EMB affects both Nat and Pol inducing analogous conformational rearrangements 
in the two conformers.
Figure 4. Analysis of the NS/EMB protein-ligand complexes by native MS. Nano-ESI-MS spectra of SEC 
fractions of (A) monomeric Nat; (B) enlargement of the 15+ peak shown in (A), the arrow indicates the 
expected position of the 1:1 NS/EMB complex. (C) monomeric species of Nat incubated overnight with EMB 
(E) at 20 °C; (D) enlargement of the 15+ peak in (C), the arrow indicates the expected position of the 1:1 NS/
EMB complex; (E) NS oligomers after incubation as in (C); (F) enlargement of the peak corresponding to the 
dimer 21+ in (E); (G) enlargement of the peak corresponding to the trimer 27+ in (E). (H) enlargement of the 
peak corresponding to the tetramer 32+ in E. (I) Average charge state of the monomer (M), dimer (D), trimer 
(T) and tetramer (Q) as a function of mass, compared to globular structures (black line31). Black numbers 
indicate charge states, red numbers indicate the molecules of bound ligand.
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Figure 5. Analysis of the interaction between NS and EMB by circular dichroism (CD). (A) CD spectra of 
Nat and Pol with or without EMB: Nat (black line); Pol (red line); Nat and Pol incubated for 2 hours at 55 °C 
with EMB (green line and blue line, respectively). (B) Temperature ramps of Nat and Lat alone (−EMB) and 
in the presence of EMB (+ EMB) monitored through far-UV CD at 218 nm. The black lines indicate the CD 
signal of the samples heated up from 20 to 95 °C; the grey lines correspond to samples cooled down from 95 to 
20 °C. (C) The affinity of four different anti-NS monoclonal mAb (1A10, 10B8, 10G12 and 7C6) against NS was 
measured by sandwich ELISA on four gel filtered species: Pol; NS/EMB olig1 (NS/EMB largest oligomers eluted 
at 8.5–9 ml as in Fig. 1A); NS/EMB olig2 (NS/EMB smaller oligomers eluted at 10–10.5 ml as in Fig. 1A); and 
NS/EMB dim (NS/EMB dimers eluted at 12.5 ml as in Fig. 1A).
www.nature.com/scientificreports/
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Temperature-dependent conformational changes have been monitored by CD at 218 nm for the Nat and Lat 
conformers, analogously to a previous report23. When native NS is heated up from 20 to 95 °C, the CD trace is 
characterized by the presence of two incremental ellipticity steps at about 55 and 85 °C (Fig. 5B top-left black line), 
corresponding to the Nat to Lat transition (namely, latent 45 in23), and to the transition from latent45 to latent8523. 
The temperature ramp of Lat (Fig. 5B bottom-left) shows only a change in the CD signal at 85 °C corresponding 
to the formation of latent8523. Such transitions are irreversible (Fig. 5B grey lines). Remarkably the temperature 
ramp profiles of Nat/EMB and Lat/EMB complexes behave similarly in the presence of EMB: the ellipticity changes 
described above are no longer visible and only a very contained increase in CD signal can be observed in the 
70–80 °C range (Fig. 5B right panels). CD temperature ramps measured for Cle and Cle/EMB are identical, with 
no observable changes in ellipticity (data not shown).
To further compare the conformational assembly of Pol with oligomeric NS/EMB, the affinity of four different 
anti-NS monoclonal antibodies (mAbs)19 for Pol and NS/EMB oligomers was verified in a sandwich ELISA. EMB 
free Pol (prepared by incubation of Nat at 45 °C) was compared with dimeric and oligomeric NS/EMB (Fig. 5C). 
All protein samples were freshly purified by GF before being tested by ELISA. As reported in Fig. 5C, all four mAbs 
showed a high affinity for Pol, in agreement with previous results19, while none of the mAbs displayed a measurable 
binding to the NS/EMB species.
The NS/EMB complex does not inhibit the activity of tPA. Next the influence of EMB on NS activity 
was evaluated following the inhibition of tPA hydrolytic activity. Due to direct inhibitory effect of EMB on tPA, 
however, free EMB could not be added to the reaction mixture (data not shown). Therefore the SEC purified mon-
omeric NS/EMB and dimeric NS/EMB complexes-i.e. the species eluted at 13.5 and 12.5 ml, respectively-were 
tested.
First a tPA inhibitory assay was performed based on the chromogenic substrate IPR-pNA (Fig. 6A). In the 
presence of Nat ([NS] = 60 nM), the active form of recombinant tPA (2ctPA) is inhibited and hydrolysis of the 
synthetic substrate is reduced, compared to free 2ctPA, in keeping with previous results22 (Fig. 6A blue and orange 
curves, respectively). Conversely, when 2ctPA activity is assayed in the presence of monomeric, dimeric NS/EMB 
and oligomeric complexes (green, dashed, grey and yellow curves, respectively), the substrate is hydrolysed as 
efficiently as in the absence of NS (2ctPA alone, orange curve).
Formation of the covalent NS/2ctPA complex and the cleavage of NS by 2ctPA were analysed in parallel though 
SDS-PAGE. In the absence of EMB (Fig. 6B top panel) formation of the acyl-enzyme complex (NS/2ctPA) is evi-
dent, disappearing after one hour; after two hours Nat is almost completely cleaved (15% Nat, 85% Cle). When 
monomeric or dimeric NS/EMB complexes were tested, two important differences could be noticed (Fig. 6B middle 
and bottom panels). Firstly no covalent NS/2ctPA complex was detected from SDS-PAGE, in keeping with what 
has been observed for PAI-128, and consistent with the lack of inhibition displayed by the NS/EMB complexes. 
Secondly, both monomeric and dimeric NS/EMB complexes are hydrolysed by 2ctPA, though to different extent. 
Within the time range of the experiment about 30% of the monomeric complex is cleaved by 2ctPA, while about 
18% of the dimeric NS/EMB complex is cleaved after 120 minutes (Fig. 6B bottom panel). Thus dimeric NS/EMB 
is less efficiently cleaved by tPA, an indication that the RCL is less solvent exposed in the dimeric species.
Discussion
NS polymerization is responsible for a genetic encephalopathy known as FENIB32. The accumulation of NS pol-
ymers leads to intracellular depositions known as Collins bodies, their size and amount correlating well with the 
severity of the symptoms19,33. FENIB is a progressive and fatal disease for which, to date, no treatment is available. 
A therapeutic intervention based on our general understanding of the molecular bases of the disease should be 
based on efficient inhibition of NS polymerisation. Considering the structural similarity relating the two serpins 
PAI-1 and NS, our work explored the inhibitory properties of EMB, a small natural molecule recently proven to 
interact specifically with native PAI-128.
Our results show that EMB is able to bind all the NS conformers (Nat, Pol, Lat and Cle), opposite to what has 
been previously reported for PAI-1 where EMB binding was specific for the native conformation28. In the case 
of NS, the interaction of EMB destabilises the native conformation and trigger the formation of small oligomers. 
Such aggregation reaction can be accelerated by an increase in temperature or in protein concentration (Fig. 1 
and S2). More specifically, we first observed the formation of a monomeric NS/EMB complex, shortly followed 
by the appearance of a dimeric species; at equilibrium, in all the tested temperatures and protein concentrations, 
an ensemble of oligomers ranging between 2 and 8 molecules was observed. All the oligomers formed upon 
incubation have EMB molecules bound (Fig. 3) with a 1:1 (NS:EMB) stoichiometric ratio (Fig. 4). In all oligomers 
the assembled NS molecules display a compact fold (Fig. 4I), with minor changes in secondary structure content 
(Fig. 5A). EMB binding alters the stability of the NS conformers: the conformational changes typical of NS previ-
ously reported23- i.e. secondary structure gain at 55 and 85 °C – are not observed in the presence of EMB (Fig. 5B).
The NS polymeric conformation is known to be very stable, such that chemical unfolding has been so far 
the only way to disaggregate NS polymers23. Unexpectedly, EMB triggered polymer breakdown resulting in the 
accumulation of smaller oligomers, which also formed upon incubation of Nat and, remarkably, Lat with EMB. 
Conversely Cle binds EMB but remains monomeric (Fig. 3). The inability of Cle to form oligomers may be due to 
the lack of an intact and uncleaved RCL, or to the very high stability of this conformer.
Several pieces of evidence suggest that the presence of EMB drives NS away from the canonical aggregation 
pathway resulting in polymeric and latent forms and it leads to the formation of oligomers, which are species 
distinct from the polymers: I) while Nat incubated at high temperatures forms increasingly bulky polymers and 
some Lat form, in the presence of EMB the oligomers do not grow beyond the range of 2-8 NS molecules and no 
Lat is observed (Fig. 2A, S1). Atomic force microscopy images show clear morphological differences between Pol 
and NS/EMB: the former is shaped as elongated chains the latter displays a compact ellipsoidal shape (Fig. S7). II) 
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Pol disaggregates upon incubation with EMB (Fig. 3B and S1); and III) the difference in spectroscopic properties 
suggests that the NS/EMB oligomers are qualitatively distinct from NS polymers (Figs 2B, 5A). IV) Monoclonal 
antibodies raised against pathological S49P NS polymers that recognize polymers of NS formed by cultured cells do 
not bind to NS/EMB oligomers (Fig. 5C). Taken together, our results show that the interaction with EMB modifies 
markedly the NS conformational landscape.
Native NS conformation is known to be metastable and, in destabilised mutants (or by destabilisation of wt NS 
in vitro), it generates Pol and Lat conformers, which are known to be the most stable uncleaved species13,17,18. In the 
presence of EMB all the uncleaved conformers behave similarly and converge towards the formation of an ensemble 
of small oligomers (Fig. 3A–C, S1), which do not resemble in stability and behaviour the known NS polymers.
These results may bear relevant implications. It is widely accepted that incubating wt NS at temperatures ranging 
between 37 and 55 °C results in the formation of Lat and Pol conformers, closely resembling those produced by the 
pathologic mutant variants7,17,23. The intracellular accumulation of mutant NS polymers is toxic to neurons in the 
FENIB dementia, as shown in a Drosophila model of FENIB19 and suggested by the lack of an evident phenotype 
in NS-deficient mice34. The NS oligomers formed in the presence of EMB are much smaller than the polymers 
and highly soluble. Therefore, the NS/EMB oligomers may be more efficiently secreted and/or degraded by cells, 
as suggested by their susceptibility to tPA cleavage in vitro, instead of being further accumulated into insoluble 
intracellular inclusions as seen in the disease32,35,36. Such effects, however, require in vivo validation before a claim 
on an actual EMB detoxifying effect can be released.
Although an ideal intervention for FENIB should prevent polymer formation without affecting the physiolog-
ical activity of monomeric NS, the observed lack of NS inhibitory activity on tPA in the presence of EMB might 
underlie an unexpected therapeutic application. Brain metastasis is one of the most devastating complications 
Figure 6. Inhibition of 2ctPA by NS/EMB complex. (A) Chromogenic 2ctPA inhibition assays following the 
hydrolysis of IPR-pNA (250 μ M) by 2ctPA (1 nM) alone (orange curve) in the presence of Nat (cyan) and of NS/
EMB complex at different oligomeric states (60 nM): monomer (green), dimer (magenta), largest oligomers 
eluted at 8.5–9 ml as in Fig. 1A (olig1, red), smaller oligomers eluted at 10–10.5 ml as in Fig. 1A (olig2, blue). 
(B) Nat, monomeric or dimeric NS/EMB complex (2.4 μ M) were incubated with 2ctPA (0.4 μ M) as in A and the 
samples analysed by SDS-PAGE. Lane 1: molecular marker; lane 2: Nat; lanes 3–10: 1, 5, 15, 30, 45, 60, 90, and 
120 min time points. Nat, Cle and acyl-enzyme complex of NS with 2ctPA (cpx) bands are indicated.
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of primary cancer37. A recent report uncovered a role for NS in facilitating the propagation of brain metastases 
through the inhibition of tPA proteolytic activity21; in this context, NS removal reduced drastically the probability 
of brain metastasis. Thus, we propose that a low molecular weight compound such as EMB might provide a new 
avenue to impair NS pro-metastatic activity in the context of a brain oncologic disease.
Although further work is needed to understand the details of the interaction between EMB and the NS con-
formers, our results show for the first time that a small molecule is able to dissolve already formed NS polymers, 
and to inhibit the formation of long-chain polymers, shedding novel suggestions for the search drug leads against 
FENIB. Furthermore, inhibition of NS by small molecules may also find interesting applications in distinct human 
pathologies. Although EMB has been ascribed many biological activities, ranging from modulation of apoptosis to 
modification of gene expression38–40, which could discourage its direct use as a drug, our work provides an original 
proof-of-principle for future applications of small molecules interventions for FENIB and other serpinopathies.
Methods
NS expression and purification. NS was expressed and purified according to22.
Production of NS conformers. Lat and Pol were prepared by incubating Nat overnight (0.5 and 4 mg/ml, respec-
tively) at 45 °C in 10 mM Tris, 50 mM KCl, pH 8.0. The two species were subsequently purified by SEC (Superdex 
200 10/300 GL, GE Healthcare, Little Chalfont, UK). The Cle conformer was prepared as described in22.
Incubation with Embelin. In order to prepare EMB solutions with a controlled concentration we tested two 
strategies. In the first approach, following a conventional route, EMB was solved into a high concentration stock 
solution in dimethyl-sulfoxide (DMSO), up to EMB solubility in DMSO (120 mM) and then diluted 1:1000 in 
the final NS solution. Such a high dilution is required since a DMSO content higher than 0.5% (v/v) affects NS 
secondary structure and at any concentration DMSO has a pro-polymerisation effect. Moreover, the actual EMB 
solubility in 0.1% DMSO solution is even lower than 120 μM thus not playing any beneficial effects on EMB solu-
bility. The above technical issues do not allow reaching a high stoichiometric ration between EMB and NS, which 
is necessary to efficiently drive their interaction.
In order to overcome these experimental constraints, we envisaged an alternative strategy able to avoid the 
presence of organic solvents and enhance the interaction of EMB with NS. EMB powder (Sigma) was directly 
added to the NS solution (10 mM Tris HCl, 50 mM KCl, pH 8.0) and thoroughly dissolved until reaching saturation 
conditions. The solution was then immediately centrifuged at 4 °C for 10 minutes at 20000 rcf in order to remove 
the excess of insoluble EMB. Due to the limited EMB solubility such method allowed to reproducibly reach the 
saturated concentration of 1.5 mM. EMB concentration was monitored by measuring EMB absorbance at 325 nm 
(ε = 24000 M−1 cm−1 at pH 7.4). The supernatant was then used for the experiments described below. Specific 
incubations of Nat were performed at different temperatures as described in the figure legends: overnight at 4 mg/
ml, or at 1.7 mg/ml. In all cases, at the end of the incubation, the NS/EMB samples were centrifuged at 4 °C for 
10 minutes at 20000 rcf and the supernatant analysed by different techniques.
SEC-FPLC. All the analytical SEC runs were performed using a Superdex200 10/300 GL column (GE Healthcare) 
in 10 mM Tris HCl, 50 mM KCl, pH 8.0 buffer.
SEC-HPLC. NS samples consisting of 200 μ L at 4 mg/mL were separated using an HPLC system composed by a 
Waters 515 HPLC Pump connected with different detectors, as needed.
SEC-MALS. Molar mass of low molecular weight species generated after incubation of Nat with EMB were 
characterized by connecting on-line the SEC-HPLC system with a Dawn® Heleos® Multi Angle Light Scattering 
(Wyatt, Santa Barbara, CA, USA), a Waters 2487 Dual λ Absorbance Detector and a Optilab® T-rEX Refractive 
Index Detector (Wyatt, Santa Barbara, CA, USA). Molar mass at different volumes of elution was calculated by 
Astra software (v. 5.3.4.18, Wyatt, Santa Barbara, CA, USA) by using 0.185 as dn/dc value.
Multi-wavelength HPLC. Multi-wavelength HPLC runs were carried out by connecting on-line the SEC-HPLC 
system with a Waters 996 Photodiode Array Detector. Chromatograms at specific wavelengths (280 and 340 nm 
for proteins and EMB, respectively) and UV-vis spectra of peaks were extrapolated by means of Waters Empower 
Pro software. NS does not display any absorbance at 340 nm and EMB incubated in the absence of NS is eluted at 
much higher volume in SEC, as typical for small organic molecules (data not shown).
Native polyacrylamide gel electrophoresis. Native-PAGE gels, consisting of a 7.5% acrylamide resolving gel and 
a 5% stacking gel, were run at 90V on ice to prevent sample denaturation and polymer dissociation in standard 
sample and running buffers according to41. Nat concentration was 4 mg/ml in both samples.
ESI-MS analysis. Samples for ESI-MS analyses contained 100 mM ammonium acetate pH 8, and either native or 
pre-incubated NS at 10–20 μ M total protein concentration. The analyses were performed on a hybrid quadrupole 
time-of-flight mass spectrometer (QSTAR Elite, AB-Sciex, FosterCity, CA, USA), equipped with a nano-ESI source. 
Samples were infused through metal-coated borosilicate capillaries, with emitter tips of 1 μm internal diameter 
(Proxeon, Odense, Denmark). The following instrumental setting was applied: positive ion-mode, declustering 
potential 300 V, ion spray voltage 1.3 kV and curtain-gas pressure 20 psi. Unusually high values of declustering 
potential were necessary to counteract adduct formation during the electrospray. The sample source and the 
instrument interface were kept at room temperature. Data were analyzed using the Analyst 2.0 software.
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Photoluminescence. PL measurements were performed by incubating 5 μ M NS samples (with or without EMB 
incubation) on a Jasco FP-6500 spectrofluorimeter using a quartz cuvette with a 1.5 mm optical path. The temper-
ature was controlled within 0.05 °C with a temperature-controlled recirculating bath. The normalised emission 
bands PL(λ ) were measured with a 275 nm excitation wavelength, buffer subtracted and normalised by the total 
PL area. The first momentum λ 1 of the emission band was calculated as λ 1 = ∫ λ PL(λ )dλ .
Circular Dichroism. CD experiments were carried out on a J-810 spectropolarimeter (JASCO Corp., Tokyo, Japan) 
equipped with a Peltier system for temperature control using a 0.1 cm path length cuvette. The CD spectra shown 
in figure 5A have been measured on 12.3 μ M solution of Nat and Pol NS in 50 mM KCl, 10 mM Tris-HCl, pH 8.0, 
with or without incubation with EMB. NS samples were incubated in saturated EMB solution as described above 
and then washed by spin columns to remove excess EMB before collecting the CD spectrum. The Pol NS samples 
(with or without EMB) were formed upon incubation of Nat solution at 55 °C for two hours, residual monomeric 
NS was removed by spin columns (cut-off 100kDa). All measurements were performed at pH 8.0, 20 °C, with an 
optical path of 0.1 cm.
For the temperature ramp experiments, ellipticity at 218 nm wavelength was recorded from 20 to 95 °C (tem-
perature slope 1.0 °C/min) on NS samples (Nat, Lat and Cle with or without EMB) in 50 mM KCl, 10 mM Tris-HCl, 
pH8.0, at a NS concentration of 0.25 mg/ml. NS samples were incubated for 30 minutes at 4 °C in a saturated EMB 
solution, then centrifuged for 10 minutes at 20000 rcf before starting the temperature ramps.
Sandwich ELISA. The affinity of anti-NS monoclonal antibodies (mAb)19 for NS conformers with and without 
EMB was quantified by sandwich ELISA as described previously19. Briefly, 96-well plates (Corning Inc., Costar 
3590) were coated with antigen-purified rabbit polyclonal anti-NS antibody (2 μ g/ml), washed (0.9% w/v NaCl, 
0.05% v/v Tween20) and blocked with blocking buffer (PBS, 0.25% w/v bovine serum albumin, 0.05% v/v Tween20, 
0.025% w/v Na azide). Gel filtered NS conformers and NS/EMB complexes were diluted in blocking buffer and 
incubated for 2 h. After washing, wells were incubated with each mAb (1A10, 10B8, 10G12 and 7C6) from 10 μ g/
ml with serial dilutions. Rabbit anti-mouse IgG-HRP labeled antibody was used for detection with TMB substrate 
solution, and HRP activity was measured in a GloMax plate reader (Promega) at 450 nm. The interplate and 
intraplate coefficient of variation were both less than 5%.
NS inhibition kinetics. The progress curves for the inhibitory reaction of NS on 2ctPA (American Diagnostica) 
were determined in the presence of the chromogenic substrate H-D-Ile-Pro-Arg-p-nitroanilide (IPR-pNA; 
Chromogenix) by recording the formation of pNA upon cleavage of the substrate. Experiments were performed at 
25 °C in 50 mM Tris, 10 mM Na2HPO4, 150 mM NaCl, and 0.1% Tween (pH 7.4). Buffer, NS (60 nM), and substrate 
(250 μ M) were mixed in a 2 ml cuvette and reactions were initiated by addition of a fixed amount of 2ctPA (1 nM). 
Product accumulation was continuously recorded by a Cary 4E spectrophotometer (Varian, Inc.) at 405 nm. The 
experiment, as shown in Fig. 6, was repeated three times.
Formation of NS/tPA acyl–enzyme complex. Samples of different NS species were incubated with 2ctPA at a 
6:1 (NS:2ctPA) molar ratio in the same buffer as for the chromogenic assays. The reactions were stopped at time 
intervals by addition of a denaturing buffer containing Na dodecyl-sulphate and β -mercaptoethanol followed by 
heating for 10 min at 100 °C. Samples were analysed by SDS-PAGE in 10% separating polyacrylamide gels. After 
electrophoresis, proteins were stained with SYPRO Ruby (Molecular Probes) and visualized with a Typhoon 9200 
laser scanner. Protein quantification was performed using ImageQUANT software (GE Healthcare Life Sciences).
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